Bimergen Energy Anticipates Uplist to the NYSE American Stock Exchange with Concurrent Offering Next Week
Rhea-AI Summary
Bimergen Energy (OTCQB: BESS) announced that its common stock has been approved for listing on the NYSE American. The company expects trading on NYSE American under the symbol BESS to begin at the market open on or about December 18, 2025, subject to exchange authorization and continued compliance with exchange rules.
Shares are expected to continue trading on the OTCQB until the close of market on or about December 17, 2025, after which OTCQB trading will terminate upon the NYSE American listing becoming effective. In connection with the anticipated uplisting, Bimergen is conducting a concurrent offering of securities, subject to market conditions and regulatory approval; further offering details will appear in the company’s SEC filings. Stockholders need not take any action before the listing.
Positive
- Expected NYSE American listing on Dec 18, 2025
- OTCQB trading to continue until Dec 17, 2025
- Company pursuing a concurrent offering to raise capital
Negative
- NYSE listing contingent on exchange authorization and compliance
- Concurrent offering subject to market conditions and regulatory approval
News Market Reaction
On the day this news was published, BESS declined 23.08%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Key renewable peers showed mixed moves: CLNV gained 14.29% and WNDW rose 9.49%, while others like REVVF, GEBRF, and RROYF were flat. With BESS down 3.7%, the action appears more stock-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 05 | Uplist & offering | Positive | +11.8% | Announced NYSE American uplist approval with concurrent offering underway. |
| Nov 12 | Strategic partnership | Positive | +8.9% | Joint development agreement with Eos Energy for U.S. storage projects. |
| Oct 21 | Leadership change | Positive | -0.9% | Appointed co-CEOs while highlighting financing to advance 2 GW pipeline. |
| Oct 07 | Equity commitment | Positive | +5.3% | Announced up to $200M equity commitment to accelerate 2 GW BESS pipeline. |
| Oct 02 | Capital commitment | Positive | +3.7% | Secured $50M commitment via JV for up to 2 GW battery projects. |
Over the past six months, positive financing, partnership, and uplisting updates often coincided with positive price reactions, with only one mild divergence on leadership changes.
Recent news for Bimergen centered on capital formation and strategic positioning. On Dec 05, 2025, an earlier NYSE American uplist and concurrent offering announcement saw a 11.76% gain. Prior releases from Oct–Nov 2025 detailed joint development with Eos Energy, multiple equity and capital commitments up to $250 million, and boardroom changes creating co-CEOs. These moves aimed to advance a multi‑GW BESS pipeline. Today’s uplist-timing update and concurrent offering plans build directly on that ongoing IPO and capital-raising process.
Market Pulse Summary
The stock dropped -23.1% in the session following this news. A negative reaction despite the uplisting update could reflect concerns about dilution and balance sheet risks. The S-1/A details 1,321,586 new shares at an assumed $9.08, with shares outstanding projected to rise from 3,857,906 to 5,179,492. Regulatory filings also show a Q3 net loss of $1,795,478 and cash of only $74,087, alongside going-concern warnings, which may overshadow listing benefits.
Key Terms
NYSE American regulatory
OTCQB regulatory
Securities and Exchange Commission regulatory
AI-generated analysis. Not financial advice.
Newport Beach, CA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (OTCQB: BESS) (“Bimergen”), a utility-scale battery energy storage systems (BESS) asset owner, project developer, and independent power provider, today announced that its shares of common stock have been approved for listing on the NYSE American LLC ("NYSE American") stock exchange. Bimergen expects that its common stock will begin trading on the NYSE American under the symbol “BESS” at the opening of trading on or about December 18, 2025, subject to authorization of the application and continued compliance with the exchange rules.
In connection with the anticipated uplisting, Bimergen is also conducting a concurrent offering of its securities, subject to market conditions and regulatory approval. Additional details regarding the offering will be provided through the Company’s filings with the Securities and Exchange Commission (“SEC”).
Bimergen expects that its shares of common stock will continue to trade on the OTC Markets’ OTCQB until the close of the market on or about December 17, 2025. Upon effectiveness of the listing on the NYSE American, trading of the common stock on the OTCQB will terminate. Stockholders of Bimergen do not need to take any action prior to the listing of Bimergen’s shares on the NYSE American.
This communication does not constitute an offer, or a solicitation of an offer, to buy or sell any securities, investment or other specific product, or a solicitation of any vote or approval, nor shall there be any sale of securities, investment or other specific product in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
About Bimergen Energy Corporation
Bimergen Energy Corporation (OTCQB: BESS) is a U.S.-based independent power producer specializing in the development, ownership, and operation of standalone battery energy storage systems (BESS). Bimergen develops utility-scale and distributed storage projects designed to provide grid reliability, renewable integration, and flexible energy solutions. Bimergen manages the full project lifecycle, including site selection, permitting, engineering, procurement, construction, and operations. Its portfolio spans multiple power markets across the United States.
Cautionary Note Regarding Forward-Looking Statements
This press release may include, and oral statements made from time to time by representatives of Bimergen may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, Bimergen’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in Bimergen’s filing with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Bimergen, including those set forth in the Risk Factors section of Bimergen’s filings with the SEC. Bimergen undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact:
Dave Gentry
RedChip Companies Inc.
1-407-644-4256 | 1-800-REDCHIP (733-2447)
BESS@redchip.com
FAQ
When will Bimergen (BESS) begin trading on NYSE American?
Will Bimergen (BESS) continue trading on OTCQB after the NYSE listing?
Do Bimergen shareholders need to take action before the NYSE American uplisting?
What does the concurrent offering mean for Bimergen (BESS)?
Is the NYSE American listing guaranteed for Bimergen (BESS)?
